- Abzena History
We are proud of our 20+ years
of history moving medicine forward.
- About Abzena
We are a leading complex biologics
and bioconjugates CDMO + CRO.
- Abzena Locations
We operate from state-of-the-art
facilities in the US and the UK.
- Moving Medicine Forward
It's what we do. We take on complex
biologic & bioconjugate programs.
- Abzena History
Search results
Fusion Antibodies up 12% on cash runway relief
Proactive Financial News· 3 days agoFusion Antibodies PLC (AIM:FAB) saw its shares rise by 12% after confirming it has a cash runway extending into the second quarter of 2025. Fusion,...
Mammalian cell display with automated oligo design and library assembly allows for rapid residue...
Nature· 4 days agoUsing a new method for rapid, residue-level epitope determination combining flow cytometry and surface displayed alanine substitution variants the authors determined the epitopes of three new antibodies binding the SARS-CoV-2 Spike protein.
FDA approves third anti-amyloid antibody for Alzheimer disease
Nature· 2 days agoDiscover the world’s best science and medicine | Nature.com
Food intolerance tests: Helpful for identifying gut issues or a money-grabbing gimmick?
Women's Health UK via Yahoo News· 5 days agoSuspect something may not be agreeing with you and considering taking a food intolerance test? With...
FDA approves Lilly’s new Alzheimer’s drug after delay
The Hill via Yahoo News UK· 4 days agoThe Food and Drug Administration (FDA) on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company...
Tackling Hard-To-Treat Tumors
Forbes· 4 days agoOne of the ways researchers are trying to address this problem is by disarming the tumor’s defenses against the immune system. This article describes one such effort: a novel antibody ...
Nipocalimab pivotal Phase 3 trial demonstrates sustained disease control in FcRn class for a broad...
PharmiWeb· 6 days agoJanssen-Cilag International NV, a Johnson & Johnson company today announced positive results from the nipocalimab Phase 3 Vivacity-MG3 study in patients with generalised myasthenia gravis (gMG ...
'Microdosing' candies linked to illness, death, and a new Alzheimer's drug: A look at health stories...
Yahoo Life· 8 hours agoIt will be sold under the brand name Kisunla. The drug, which was cleared for adults with mild...
FDA approves a second Alzheimer's drug that can modestly slow disease
Associated Press via Yahoo News UK· 4 days agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing...
Nanorobots with 'lethal weapons' destroy cancer cells & stop tumours spreading
The Irish Sun· 5 days agoIT’S a worrying fact that more than half of us will get cancer in our lifetime. Perhaps the most...
